share_log

BRIEF-Syndax Pharmaceuticals Reports Q4 Financial Results

路透社 ·  Mar 9, 2021 05:33
March 8 (Reuters) - Syndax Pharmaceuticals Inc :
   * SYNDAX PHARMACEUTICALS REPORTS FOURTH QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CLINICAL AND BUSINESS UPDATE
   * Q4 LOSS PER SHARE $0.44
   * Q4 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES DATA
   * END OF YEAR CASH BALANCE OF $293.1 MILLION PROVIDES CASH RUNWAY INTO 2023

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment